Pharmerica (PMC) Tops Q4 EPS by 2c

Pharmerica (NYSE: PMC) reported Q4 EPS of $0.45, $0.02 better than the analyst estimate of $0.43. Revenue for the quarter came in at $523.5 million versus the consensus estimate of $491.99 million.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04